Top compounds associated with response to ARL3


Feature Type Standardized
Nominal ANOVA
mRNA niclosamide CTRPv2 pan-cancer AAC 0.16 4e-05
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 5e-05
mRNA FK866 CTRPv2 pan-cancer AAC 0.16 6e-05
mRNA lapatinib CCLE pan-cancer AAC -0.18 7e-05
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 9e-05
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 9e-05
mRNA neratinib CTRPv2 pan-cancer AAC -0.15 0.0001
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 0.0001
mRNA Vorinostat GDSC1000 pan-cancer AAC 0.13 0.0001
mRNA EKB-569 GDSC1000 pan-cancer AAC -0.13 0.0002
Download CSV